Krystal Biotech Inc (KRYS)
158.52
-2.31
(-1.44%)
USD |
NASDAQ |
Dec 24, 16:00
Krystal Biotech Cash from Investing (Quarterly): -34.33M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Bioventus Inc | -0.064M |
| ADMA Biologics Inc | -1.098M |
| Alnylam Pharmaceuticals Inc | -30.25M |
| Amicus Therapeutics Inc | 34.27M |
| Insmed Inc | -1.003B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 58.86M |
| Cash from Financing (Quarterly) | 3.365M |
| Free Cash Flow | 58.06M |
| Free Cash Flow Per Share (Quarterly) | 1.933 |
| Free Cash Flow to Equity (Quarterly) | 57.81M |
| Free Cash Flow to Firm (Quarterly) | 57.81M |
| Free Cash Flow Yield | 1.24% |